Zoetis
 |
|
| Public | |
| Traded as | : ZTS S&P 500 Component |
| Industry | Pharmaceutical |
| Founded | 1952 |
| Headquarters | Parsippany, New Jersey, United States |
|
Area served
|
Worldwide |
|
Key people
|
Juan Ramon Alaix (CEO) |
| Revenue |
 US$ 4.8 billion (2014) |
|
US$ 583 million (2014) |
|
|
Number of employees
|
9500 |
| Website | Zoetis |
Zoetis, Inc. (/zō-EH-tis/) is the world's largest producer of medicine and vaccinations for pets and . The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company operates in 70 countries worldwide with recent expansions into Southeast Asia and China. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.
In the 1950s, Pfizer began research on several drugs including Oxytetracycline. John McKeen, a chemical engineer with Pfizer products, discovered its effective use in livestock. In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana called Vigo. By 1988 the division was renamed Pfizer Animal Health.
The acquisition of GlaxoSmithKline’s Norden Laboratories in 1995 boosted Pfizer's animal health division into small animal care including domestic pets. Secondary research and development centres were opened in Kalamazoo, Michigan in 2003. In the same year, Pfizer acquired Pharmacia Corporation for US$ 60 billion in stock options. Between 2007 and 2011 the company acquired Embrex Inc, Catapult Genetics, Bovigen, Wyeth, Fort Dodge Animal Health, Vetnex Animal Health Ltd, Synbiotics Corporation, Microtek, King Pharmaceuticals, and Alpharma. These acquisitions greatly increased Pfizer's market, range of products, countries it operated in, and resources.
...
Wikipedia